Systematic Review
Copyright ©2014 Baishideng Publishing Group Inc.
World J Gastrointest Oncol. Jun 15, 2014; 6(6): 184-193
Published online Jun 15, 2014. doi: 10.4251/wjgo.v6.i6.184
Table 3 Oncological outcomes
Ref.No. of patients
Mean follow-up (mths)
NeoCRT (%)
Lymph nodes harvested (mean)
TME grade complete (%)
CRM +ve (%)
DRM (cm)
Robotic Recurrence (%)
3 yr Robotic Survival (%)
RobLapRobLapRobLapRobLapRobLapRobLapRobLapDSOS
Baik et al[24]565714.3 (both)8.912.218.418.792.975.47.18.84.03.6--7.6
Ng et al[40]8NA1.5NA--12.9NA--0NA> 2.0NA--NA
Patriti et al[37]293729.218.724.15.410.311.2--002.14.5None100.09.6
Bianchi et al[38]252510.0 (both)52.040.019.718.2--04.02.02.0None-6.0
Pigazzi et al[32]143NA17.4NA65.1-14.1NA--0.7NA2.9NA1.577.6NA
Zimmern et al[33]58NA13.2NA39.7NA14.1NA--0NA--5.2-NA
Baek et al[34]4141--80.543.913.116.2--2.44.93.63.8--6.6
Koh et al[41]20NA--9.5NA17.8NA--5.3-3.7---NA
Kwak et al[25]596017.013.013.68.520.021.0--1.70-----
Leong et al[26]29NA--37.9NA16.0NA--7.0NA0.8NA--NA
Park et al[27]52123--23.18.119.415.9--1.92.42.83.2--9.8
Kim et al[28]100NA24.0NA32.0NA20.0NA--1.0NA2.7NA--NA
Park et al[35]30NA--66.7NA20.0NA83.3NA0NA----NA
Shin et al[29]1712----18.4215.92--------9.6
Erguner et al[42]2737--14.821.616.016.0100.070.6004.04.0--5.0
Kang et al[30]16516522.41 (both)23.621.815.015.6--4.26.71.92.0---
Park et al[31]40406.06.080.05012.913.3--7.55.01.41.3---
Stanciulea et al[43]100NA24.01NA58.0NA14.01NA--1.0-3.0-2.0NA90.0
D’Annibale et al[39]505012.012.068.056.016.513.8--003.03.0---
Fernandez et al[36]1359--77.054.016.020.069.073.002.0-----